Author

Hillary M. Sedlacek

Observed name: Hillary Sedlacek

Institutions: Case Comprehensive Cancer Center, Case Western Reserve University

Observed institutions: University Hospitals of Cleveland, University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center, Case Western Reserve University

OpenAlex ID: A5021706688

Plasma Vascular Endothelial Growth Factor Concentrations after Intravitreous Anti–Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema

2018 · Lee M. Jampol, Adam R. Glassman, et al. · Ophthalmology · 43

The comparative effectiveness of decision aids in diverse populations with early stage prostate cancer: a study protocol for a cluster-randomized controlled trial in the NCI Community Oncology Research Program (NCORP), Alliance A191402CD

2018 · Joel E. Pacyna, Simon Kim, et al. · BMC Cancer · 13

Comparative Effectiveness of Surgical Treatments for Small Renal Masses

2017 · Shree Agrawal, Hillary Sedlacek, et al. · Urologic Clinics of North America · 6

Association of race and margin status among patients undergoing robotic partial nephrectomy for T1 renal cell carcinoma: Results from a population-based cohort

2017 · Victor S. Chen, Robert Abouassaly, et al. · Urologic Oncology Seminars and Original Investigations · 5

Do radiation oncologists and urologists endorse decision aids for active surveillance of low‐risk prostate cancer: Results from a national survey

2020 · Kang Puneet, Jon C. Tilburt, et al. · European Journal of Cancer Care

Lessons learned from implementing the first Alliance NCORP Research Base Cancer Care Delivery Research (CCDR) trial A191402CD.

2018 · Joel E Pacyna, Jeff A. Sloan, et al. · Journal of Clinical Oncology

Advancing the Quality of Care for Newly Diagnosed Prostate Cancer Patients: Novel Uses of Patient-Reported Outcomes

2018 · Hillary M. Sedlacek, Albert H. Kim, et al. · Annals of Surgical Oncology

Works count: 7

Citation count: 67

H-index: 4

I10-index: 2